Farallon Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-116,000
| Closed | -$4.73M | – | 171 |
|
|
2023
Q2 | $4.73M | Buy |
+116,000
| New | +$4.73M | 0.02% | 103 |
|
|
2021
Q1 | – | Sell |
-225,000
| Closed | -$12.2M | – | 243 |
|
|
2020
Q4 | $12.2M | Buy |
+225,000
| New | +$12.2M | 0.07% | 101 |
|
|
2018
Q4 | – | Sell |
-550,000
| Closed | -$15.7M | – | 97 |
|
|
2018
Q3 | $15.7M | Sell |
550,000
-290,000
| -35% | -$8.3M | 0.09% | 74 |
|
|
2018
Q2 | $23M | Buy |
840,000
+190,000
| +29% | +$5.2M | 0.14% | 60 |
|
|
2018
Q1 | $13.7M | Sell |
650,000
-490,000
| -43% | -$10.3M | 0.09% | 66 |
|
|
2017
Q4 | $21.9M | Buy |
+1,140,000
| New | +$21.9M | 0.18% | 52 |
|